Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antipsychotic Agents | 27 | 2018 | 3057 | 1.770 |
Why?
|
Clozapine | 15 | 2003 | 498 | 1.050 |
Why?
|
Psychotic Disorders | 18 | 2011 | 3046 | 0.980 |
Why?
|
Hospitals, Psychiatric | 6 | 2013 | 332 | 0.810 |
Why?
|
Bipolar Disorder | 13 | 2011 | 5027 | 0.780 |
Why?
|
Drug Utilization | 5 | 2010 | 1183 | 0.750 |
Why?
|
Psychotropic Drugs | 4 | 2012 | 894 | 0.680 |
Why?
|
Schizophrenia | 14 | 2021 | 6882 | 0.550 |
Why?
|
Hospitalization | 12 | 2013 | 10259 | 0.470 |
Why?
|
Valproic Acid | 7 | 2011 | 445 | 0.460 |
Why?
|
Mental Disorders | 6 | 2013 | 6598 | 0.410 |
Why?
|
Antimanic Agents | 4 | 2011 | 522 | 0.380 |
Why?
|
Length of Stay | 5 | 2013 | 6311 | 0.320 |
Why?
|
Leukopenia | 3 | 1998 | 213 | 0.300 |
Why?
|
Aftercare | 1 | 2013 | 870 | 0.300 |
Why?
|
Drug Therapy, Combination | 14 | 2011 | 6489 | 0.300 |
Why?
|
Piperazines | 4 | 2018 | 2488 | 0.290 |
Why?
|
Psychomotor Agitation | 1 | 2007 | 293 | 0.260 |
Why?
|
Receptors, Dopamine D2 | 2 | 2005 | 475 | 0.250 |
Why?
|
Quinolones | 2 | 2005 | 367 | 0.250 |
Why?
|
Chlorpromazine | 1 | 2004 | 111 | 0.240 |
Why?
|
Carbamazepine | 2 | 2003 | 229 | 0.220 |
Why?
|
Benzodiazepines | 4 | 2007 | 1101 | 0.220 |
Why?
|
Metabolic Diseases | 1 | 2009 | 658 | 0.220 |
Why?
|
Psychiatric Status Rating Scales | 10 | 2011 | 6036 | 0.210 |
Why?
|
Drug Administration Schedule | 10 | 2010 | 4933 | 0.200 |
Why?
|
Thiazoles | 3 | 2018 | 1483 | 0.180 |
Why?
|
Long QT Syndrome | 1 | 2004 | 453 | 0.180 |
Why?
|
Paroxetine | 2 | 1998 | 182 | 0.180 |
Why?
|
Cost of Illness | 1 | 2009 | 1860 | 0.180 |
Why?
|
Schizophrenic Psychology | 3 | 2018 | 1678 | 0.170 |
Why?
|
Comorbidity | 3 | 2010 | 10388 | 0.170 |
Why?
|
Fluoxetine | 4 | 2003 | 749 | 0.160 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2001 | 392 | 0.160 |
Why?
|
Off-Label Use | 2 | 2010 | 169 | 0.160 |
Why?
|
Adult | 35 | 2018 | 214052 | 0.160 |
Why?
|
Treatment Refusal | 1 | 2001 | 421 | 0.150 |
Why?
|
Pirenzepine | 3 | 2003 | 115 | 0.150 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2006 | 1444 | 0.140 |
Why?
|
Substance-Related Disorders | 2 | 2010 | 4257 | 0.140 |
Why?
|
Body Weight | 3 | 2007 | 4671 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2012 | 10943 | 0.140 |
Why?
|
Health Care Costs | 1 | 2009 | 3208 | 0.140 |
Why?
|
Patient Selection | 1 | 2008 | 4216 | 0.140 |
Why?
|
Anticonvulsants | 5 | 2011 | 1916 | 0.130 |
Why?
|
Middle Aged | 27 | 2018 | 213390 | 0.130 |
Why?
|
Male | 38 | 2018 | 350115 | 0.130 |
Why?
|
Overweight | 1 | 2006 | 2371 | 0.130 |
Why?
|
Female | 38 | 2018 | 380193 | 0.120 |
Why?
|
Weight Loss | 1 | 2006 | 2625 | 0.120 |
Why?
|
Antidepressive Agents | 3 | 2011 | 2838 | 0.100 |
Why?
|
Weight Gain | 2 | 2021 | 2293 | 0.100 |
Why?
|
Severity of Illness Index | 5 | 2013 | 15535 | 0.100 |
Why?
|
Delirium | 1 | 2003 | 1610 | 0.100 |
Why?
|
Depressive Disorder | 1 | 2004 | 3747 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 9955 | 0.100 |
Why?
|
Depressive Disorder, Major | 2 | 2007 | 4639 | 0.100 |
Why?
|
Humans | 47 | 2021 | 744366 | 0.100 |
Why?
|
Treatment Outcome | 14 | 2018 | 63107 | 0.100 |
Why?
|
Benzothiazoles | 1 | 2011 | 248 | 0.090 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2010 | 1953 | 0.090 |
Why?
|
Patient Compliance | 1 | 2001 | 2684 | 0.090 |
Why?
|
Pharmacy Service, Hospital | 2 | 2005 | 133 | 0.090 |
Why?
|
Mental Health Services | 1 | 2001 | 1644 | 0.090 |
Why?
|
Psychiatric Department, Hospital | 1 | 2010 | 135 | 0.090 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2010 | 170 | 0.090 |
Why?
|
Inpatients | 3 | 2005 | 2518 | 0.080 |
Why?
|
Lithium Carbonate | 2 | 2007 | 184 | 0.080 |
Why?
|
Hospitals, University | 1 | 2010 | 570 | 0.080 |
Why?
|
Polypharmacy | 1 | 2010 | 294 | 0.080 |
Why?
|
Risperidone | 3 | 2018 | 383 | 0.070 |
Why?
|
Patient Discharge | 2 | 2013 | 3318 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2001 | 3020 | 0.070 |
Why?
|
Obesity | 2 | 2006 | 12746 | 0.070 |
Why?
|
Electroencephalography | 1 | 2002 | 6151 | 0.070 |
Why?
|
Injections, Intramuscular | 1 | 2007 | 552 | 0.070 |
Why?
|
Mathematical Computing | 1 | 2005 | 147 | 0.070 |
Why?
|
Stimulation, Chemical | 2 | 1996 | 326 | 0.060 |
Why?
|
Age Factors | 3 | 2012 | 18373 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12244 | 0.060 |
Why?
|
Adolescent | 7 | 2013 | 85779 | 0.060 |
Why?
|
Antioxidants | 1 | 2011 | 1659 | 0.060 |
Why?
|
International Cooperation | 1 | 2010 | 1420 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2021 | 2716 | 0.060 |
Why?
|
Delayed-Action Preparations | 2 | 2004 | 968 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2006 | 8642 | 0.050 |
Why?
|
Diet, Reducing | 1 | 2006 | 462 | 0.050 |
Why?
|
Interview, Psychological | 1 | 2006 | 812 | 0.050 |
Why?
|
Young Adult | 4 | 2013 | 56429 | 0.050 |
Why?
|
Databases, Factual | 2 | 2009 | 7730 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2010 | 2453 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2009 | 77460 | 0.050 |
Why?
|
Drug Interactions | 2 | 1996 | 1460 | 0.050 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2005 | 430 | 0.050 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2003 | 503 | 0.050 |
Why?
|
Drug Combinations | 1 | 2005 | 1958 | 0.050 |
Why?
|
Drug Prescriptions | 2 | 2002 | 1637 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2006 | 39052 | 0.040 |
Why?
|
Hypnotics and Sedatives | 1 | 2007 | 1162 | 0.040 |
Why?
|
Aged | 8 | 2013 | 163288 | 0.040 |
Why?
|
Perphenazine | 1 | 2018 | 34 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2003 | 2708 | 0.040 |
Why?
|
Anxiety Disorders | 1 | 2010 | 2690 | 0.040 |
Why?
|
Suicide, Attempted | 1 | 2007 | 1218 | 0.040 |
Why?
|
Pilot Projects | 4 | 2011 | 8319 | 0.040 |
Why?
|
Counseling | 1 | 2006 | 1523 | 0.040 |
Why?
|
Mood Disorders | 1 | 2004 | 1106 | 0.040 |
Why?
|
Program Evaluation | 1 | 2006 | 2488 | 0.040 |
Why?
|
Time Factors | 2 | 2012 | 40075 | 0.040 |
Why?
|
Salivation | 1 | 1996 | 22 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6539 | 0.040 |
Why?
|
1-Naphthylamine | 1 | 1996 | 49 | 0.040 |
Why?
|
Chronic Disease | 2 | 2006 | 9145 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2001 | 1180 | 0.030 |
Why?
|
Affective Disorders, Psychotic | 1 | 1996 | 191 | 0.030 |
Why?
|
Sertraline | 1 | 1996 | 206 | 0.030 |
Why?
|
Body Mass Index | 2 | 2006 | 12721 | 0.030 |
Why?
|
Urination Disorders | 1 | 1996 | 241 | 0.030 |
Why?
|
Risk Factors | 3 | 2012 | 72296 | 0.030 |
Why?
|
Disease Progression | 1 | 2010 | 13286 | 0.030 |
Why?
|
Anthropometry | 1 | 1998 | 1350 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2010 | 4468 | 0.030 |
Why?
|
Liver Function Tests | 1 | 1994 | 528 | 0.030 |
Why?
|
Lithium | 1 | 1995 | 601 | 0.030 |
Why?
|
Electrocardiography | 1 | 2004 | 6442 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1995 | 1588 | 0.020 |
Why?
|
Blood Pressure | 1 | 2006 | 8551 | 0.020 |
Why?
|
Psychiatry | 1 | 2002 | 1695 | 0.020 |
Why?
|
Exercise | 1 | 2006 | 5615 | 0.020 |
Why?
|
Prolactin | 1 | 2011 | 669 | 0.020 |
Why?
|
Massachusetts | 1 | 2002 | 8662 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 1993 | 976 | 0.020 |
Why?
|
Risk | 1 | 2002 | 9688 | 0.020 |
Why?
|
Lithium Compounds | 1 | 2011 | 225 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2004 | 57776 | 0.020 |
Why?
|
Triazines | 1 | 2011 | 315 | 0.020 |
Why?
|
Epilepsy | 1 | 2004 | 3310 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4328 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2011 | 12025 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1998 | 2585 | 0.020 |
Why?
|
Drug Synergism | 1 | 2011 | 1794 | 0.020 |
Why?
|
Delphi Technique | 1 | 2010 | 779 | 0.020 |
Why?
|
Cohort Studies | 1 | 2009 | 40559 | 0.020 |
Why?
|
Risk Assessment | 2 | 2007 | 23336 | 0.020 |
Why?
|
Confidence Intervals | 2 | 2006 | 2971 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2004 | 21748 | 0.020 |
Why?
|
Logistic Models | 1 | 2001 | 13409 | 0.020 |
Why?
|
Outpatients | 1 | 2011 | 1487 | 0.010 |
Why?
|
Textbooks as Topic | 1 | 2002 | 19 | 0.010 |
Why?
|
Translations | 1 | 2002 | 64 | 0.010 |
Why?
|
Sleep | 2 | 1999 | 4622 | 0.010 |
Why?
|
Dosage Forms | 1 | 2002 | 56 | 0.010 |
Why?
|
Seizures | 1 | 1994 | 2859 | 0.010 |
Why?
|
Isoxazoles | 1 | 2002 | 216 | 0.010 |
Why?
|
Germany | 1 | 2002 | 862 | 0.010 |
Why?
|
History, 19th Century | 1 | 2002 | 720 | 0.010 |
Why?
|
Akathisia, Drug-Induced | 1 | 1999 | 67 | 0.010 |
Why?
|
Liver | 1 | 1994 | 7475 | 0.010 |
Why?
|
Receptors, Dopamine D4 | 1 | 1999 | 171 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2011 | 25039 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2004 | 7914 | 0.010 |
Why?
|
Sialorrhea | 1 | 1996 | 25 | 0.010 |
Why?
|
Acute Disease | 2 | 1999 | 7147 | 0.010 |
Why?
|
Patient Dropouts | 1 | 1999 | 420 | 0.010 |
Why?
|
Enuresis | 1 | 1996 | 47 | 0.010 |
Why?
|
Mandelic Acids | 1 | 1996 | 47 | 0.010 |
Why?
|
Parasympatholytics | 1 | 1996 | 91 | 0.010 |
Why?
|
Incidence | 1 | 1994 | 20952 | 0.010 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1996 | 91 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8340 | 0.010 |
Why?
|
Placebos | 1 | 1999 | 1676 | 0.010 |
Why?
|
History, 20th Century | 1 | 2002 | 2740 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 220 | 0.010 |
Why?
|
Piperidines | 1 | 2002 | 1602 | 0.010 |
Why?
|
Half-Life | 1 | 1993 | 661 | 0.010 |
Why?
|
Sex Factors | 1 | 2006 | 10400 | 0.010 |
Why?
|
Headache | 1 | 1999 | 1226 | 0.010 |
Why?
|
Quality Control | 1 | 1993 | 841 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1993 | 2204 | 0.000 |
Why?
|
Reference Values | 1 | 1993 | 4982 | 0.000 |
Why?
|
Depression | 1 | 2003 | 7759 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8300 | 0.000 |
Why?
|
Child, Preschool | 1 | 2004 | 41005 | 0.000 |
Why?
|
Prevalence | 1 | 1996 | 15221 | 0.000 |
Why?
|
Rats | 1 | 1993 | 24252 | 0.000 |
Why?
|
Child | 1 | 2004 | 77709 | 0.000 |
Why?
|
Brain | 1 | 1993 | 26388 | 0.000 |
Why?
|
Animals | 1 | 1993 | 168768 | 0.000 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_